Hims & Hers Health (HIMS) Interest Expenses (2020 - 2026)
Hims & Hers Health (HIMS) reported Interest Expenses of $19.4 million for Q1 2026, up 553.86% on a YoY basis from $3.0 million in Q1 2025, and up 609.84% sequentially from -$3.8 million in Q4 2025.
Hims & Hers Health (HIMS) Interest Expenses (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Interest Expenses data on file, last reported at $19.4 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 553.86% year-over-year to $19.4 million; the trailing twelve-month figure through Mar 2026 stood at $19.4 million (up 553.86% YoY), and the FY2025 full-year result was $170.5 million, down 8.03% from the prior year.
- Interest Expenses grew to $19.4 million in Q1 2026, from -$3.8 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $354.4 million in Q3 2025 to a low of -$3.8 million in Q4 2025.
- A 5-year average of $74.4 million and a median of $19.4 million in 2026 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses surged 4992.53% in 2022 and sank 445.45% in 2025, its largest moves.
- Tracing HIMS's Interest Expenses over 5 years: stood at $400000.0 in 2022, then jumped by 50.0% to $600000.0 in 2023, then surged by 83.33% to $1.1 million in 2024, then slumped by 445.45% to -$3.8 million in 2025, then jumped by 609.84% to $19.4 million in 2026.
- Business Quant data shows HIMS's Interest Expenses at $19.4 million in Q1 2026, -$3.8 million in Q4 2025, and $354.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 19.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.37 Mn |
| Mar 31, 2026 | 19.37 Mn |
| Dec 31, 2025 | -3.80 Mn |
| Dec 31, 2025 | -3.80 Mn |
| Sep 30, 2025 | 354.41 Mn |
| Sep 30, 2025 | 354.41 Mn |
| Jun 30, 2025 | 345.81 Mn |
| Jun 30, 2025 | 345.81 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 145.83 Mn |
| Sep 30, 2024 | 145.83 Mn |
| Jun 30, 2024 | 169.85 Mn |
| Jun 30, 2024 | 169.85 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | 600,000.00 |
| Dec 31, 2023 | 600,000.00 |